Rituxan (rituximab) - Roche
Adzynma (apadamtase alfa /cinaxadamtase alfa) - Takeda
Cablivi (caplacizumab-yhdp) - Sanofi
Clinical Practice Guideline: The Diagnosis, Treatment, and Follow-Up Management of Thrombotic Thrombocytopenic Purpura. (PubMed, Dtsch Arztebl Int) - Sep 30, 2026 - "The purpose of the clinical practice guideline is to improve the acute care and interdisciplinary management of TTP. Further research is needed on the use of recombinant ADAMTS13 and on the definition of uTTP (TTP in the absence of causative antibodies or genetic mutations)." 
Clinical guideline • Journal • Cardiovascular • Hematological Disorders • Thrombocytopenic Purpura • Thrombosis
http://www.ncbi.nlm.nih.gov/pubmed/42808878
 
; Albrecht Günther; Charis von Auer; Martin Bommer; Oliver Tiebel; Ralph Wendt; Susanne Unverzagt
 
Sep 30, 2026
 
Prev Next